DOCALIX

This brand name is authorized in Turkey

Active ingredients

The drug DOCALIX contains one active pharmaceutical ingredient (API):

1 Calcium dobesilate
UNII M0ROX9374L - CALCIUM DOBESILATE MONOHYDRATE

Calcium dobesilate is a regulator of capillary functions. Calcium dobesilate acts on the capillary walls by regulating its impaired physiological functions – increased permeability and decreased resistance. It increases erythrocyte flexibility, inhibits platelet hyperaggregation and, in diabetic retinopathy, it reduces plasma and blood hyperviscosity, thus improving blood rheological properties and tissue irrigation.

Read about Calcium dobesilate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C05BX01 Calcium dobesilate C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BX Other sclerosing agents
Discover more medicines within C05BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699525157737, 8699525157744

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈